Viatris (VTRS) Stock: Buy, Sell, or Hold?
VTRS - Viatris Inc. Common Stock
$17.60
0.14 (0.80%)
▲
5d:
-1.29%
30d:
+2.98%
90d:
+4.76%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When VTRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VTRS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: VTRS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.88
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$12.34
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VTRS is currently trading at $17.60, which is considered extended relative to its 30-day fair value range of $16.52 to $17.52. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.6) compared to its historical average (5.8). At these levels, the market is pricing in 4.6% annual earnings growth.
Technical Outlook: Technically, VTRS is in a strong uptrend. Immediate support is located at $16.86, while resistance sits at $18.43.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.40 (+10.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VTRS is in a strong uptrend. Immediate support is located at $16.86, while resistance sits at $18.43.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.40 (+10.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.52 -
$17.52
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.9%
Protect Your Profits
Holding VTRS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($19.40)
- BULLISH: Expecting earnings turnaround to 4.6% growth with 4.9% revenue growth
- NEUTRAL: Bottoming setup forming (45/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$16.52 -
$17.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$16.87
Resistance Level
$18.43
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.58
Wall Street Target
$19.40
(+10.2%)
Revenue Growth (YoY)
4.9%
Earnings Growth (YoY)
-70.6%
Profit Margin
-2.8%
Valuation Premium vs History
+4.6% premium
PE vs Historical
6.6 vs 5.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.6%
(market-implied from PE analysis)
1-Year Target
$18.41
(+5%)
2-Year Target
$19.26
(+9%)
3-Year Target
$20.14
(+14%)
3-Yr Target (if PE normalizes)
(PE: 7→6)
PE COMPRESSION
$17.74
(+1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 6.2%)
$65.35
(+271%)
Base:
(SPY PE: 6.6, Growth: 6.2%)
$21.09
(+20%)
Bear:
(PE: 5.6, Growth: 6.2%)
$17.93
(+2%)
Share & Embed Analysis
Last updated: October 03, 2026 6:33 PM ET
Data refreshes hourly during market hours. Next update: 7:33 PM
Data refreshes hourly during market hours. Next update: 7:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$208 | 62 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$96 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 56 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 47 HOLD |
Advanced VTRS Option Strategies
Professional options setups generated by AI based on today's VTRS price and gamma walls.
